Syros Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SYRS and buy or sell other stocks, ETFs, and their options commission-free!About SYRS
Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609.
CEONancy A. Simonian
CEONancy A. Simonian
Employees124
Employees124
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2011
Founded2011
Employees124
Employees124
SYRS Key Statistics
Market cap12.60K
Market cap12.60K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume5.31M
Average volume5.31M
High today$0.0002
High today$0.0002
Low today$0.0002
Low today$0.0002
Open price$0.0002
Open price$0.0002
Volume9.26K
Volume9.26K
52 Week high$5.22
52 Week high$5.22
52 Week low$0.0002
52 Week low$0.0002
Stock Snapshot
With a market cap of 12.6K, Syros Pharmaceuticals(SYRS) trades at $0.00.
On 2026-04-04, Syros Pharmaceuticals(SYRS) stock moved within a range of $0.00 to $0.00. With shares now at $0.00, the stock is trading 0.0% above its intraday low and 0.0% below the session's peak.
Trading activity shows a volume of 9.26K, compared to an average daily volume of 5.31M.
Over the past 52 weeks, Syros Pharmaceuticals(SYRS) stock has traded between a high of $5.22 and a low of $0.00.
Over the past 52 weeks, Syros Pharmaceuticals(SYRS) stock has traded between a high of $5.22 and a low of $0.00.
People also own
Based on the portfolios of people who own SYRS. This list is generated using Robinhood data, and it’s not a recommendation.